X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs149379-   
Low Rs82274-   
Sales per share (Unadj.) Rs84.1112.8-  
Earnings per share (Unadj.) Rs-18.3-28.4-  
Cash flow per share (Unadj.) Rs-6.7-23.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs83.788.5-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.42.9 47.4%   
Avg P/E ratio x-6.3-11.5 54.9%  
P/CF ratio (eoy) x-17.2-13.9 124.4%  
Price / Book Value ratio x1.43.7 37.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,07455,082 12.8%   
No. of employees `0002.84.3 64.1%   
Total wages/salary Rs m1,4493,457 41.9%   
Avg. sales/employee Rs Th1,874.14,434.5 42.3%   
Avg. wages/employee Rs Th527.0805.3 65.4%   
Avg. net profit/employee Rs Th-407.7-1,117.4 36.5%   
INCOME DATA
Net Sales Rs m5,15419,037 27.1%  
Other income Rs m100133 74.9%   
Total revenues Rs m5,25419,171 27.4%   
Gross profit Rs m-766-3,299 23.2%  
Depreciation Rs m711822 86.5%   
Interest Rs m1,503516 291.5%   
Profit before tax Rs m-2,881-4,503 64.0%   
Minority Interest Rs m11-13 -86.0%   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m17281 6.0%   
Profit after tax Rs m-1,121-4,797 23.4%  
Gross profit margin %-14.9-17.3 85.8%  
Effective tax rate %-0.6-6.2 9.3%   
Net profit margin %-21.8-25.2 86.3%  
BALANCE SHEET DATA
Current assets Rs m3,81013,943 27.3%   
Current liabilities Rs m8,3657,845 106.6%   
Net working cap to sales %-88.432.0 -275.9%  
Current ratio x0.51.8 25.6%  
Inventory Days Days156111 140.4%  
Debtors Days Days67124 54.2%  
Net fixed assets Rs m14,4808,127 178.2%   
Share capital Rs m6188 69.4%   
"Free" reserves Rs m9030-   
Net worth Rs m5,12714,942 34.3%   
Long term debt Rs m5,8325,251 111.1%   
Total assets Rs m19,43328,227 68.8%  
Interest coverage x-0.9-7.7 11.9%   
Debt to equity ratio x1.10.4 323.7%  
Sales to assets ratio x0.30.7 39.3%   
Return on assets %2.0-15.2 -12.9%  
Return on equity %-21.9-32.1 68.1%  
Return on capital %3.6-19.8 -18.4%  
Exports to sales %24.50-   
Imports to sales %10.20-   
Net fx Rs m5970-   
CASH FLOW
From Operations Rs m5991,625 36.9%  
From Investments Rs m-438-499 87.8%  
From Financial Activity Rs m-3034,766 -6.3%  
Net Cashflow Rs m-1415,892 -2.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.23 Rs / ZAR

Compare PANACEA BIOTECH With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: DR. REDDYS LAB  LUPIN LTD  FULFORD INDIA  ORCHID PHARMA LTD  TORRENT PHARMA  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Jan 19, 2018 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS